Cargando…

The Molecular Characteristics of Non-Clear Cell Renal Cell Carcinoma: What’s the Story Morning Glory?

Non-clear cell renal cell carcinomas are a miscellaneous group of tumors that include different histological subtypes, each one characterized by peculiarity in terms of genetic alteration, clinical behavior, prognosis, and treatment response. Because of their low incidence and poor enrollment in cli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marchetti, Andrea, Rosellini, Matteo, Mollica, Veronica, Rizzo, Alessandro, Tassinari, Elisa, Nuvola, Giacomo, Cimadamore, Alessia, Santoni, Matteo, Fiorentino, Michelangelo, Montironi, Rodolfo, Massari, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226484/ https://www.ncbi.nlm.nih.gov/pubmed/34207825 http://dx.doi.org/10.3390/ijms22126237

Ejemplares similares

An Insight on Novel Molecular Pathways in Metastatic Prostate Cancer: A Focus on DDR, MSI and AKT
por: Mollica, Veronica, et al.
Publicado: (2021)

PARP Inhibitors and Radiometabolic Approaches in Metastatic Castration-Resistant Prostate Cancer: What’s Now, What’s New, and What’s Coming?
por: Marchetti, Andrea, et al.
Publicado: (2022)

Treatment Options for Metastatic Urothelial Carcinoma After First-Line Chemotherapy
por: Tassinari, Elisa, et al.
Publicado: (2022)

Treating Prostate Cancer by Antibody–Drug Conjugates
por: Rosellini, Matteo, et al.
Publicado: (2021)

Bone Targeting Agents in Patients with Metastatic Prostate Cancer: State of the Art
por: Mollica, Veronica, et al.
Publicado: (2021)

Is There a Role for Immunotherapy in Prostate Cancer?
por: Rizzo, Alessandro, et al.
Publicado: (2020)

Metabolomic Profiling in Renal Cell Carcinoma Patients: News and Views
por: Aurilio, Gaetano, et al.
Publicado: (2021)

Bone Targeting Agents in Patients with Prostate Cancer: General Toxicities and Osteonecrosis of the Jaw
por: Mollica, Veronica, et al.
Publicado: (2022)

Prognostic Factors of Survival for High-Grade Neuroendocrine Neoplasia of the Bladder: A SEER Database Analysis
por: Mollica, Veronica, et al.
Publicado: (2022)

Adjuvant therapy in renal cell carcinoma: is it the right strategy to inhibit VEGF?
por: Mollica, Veronica, et al.
Publicado: (2021)

Adjuvant PD-1 and PD-L1 Inhibitors and Relapse-Free Survival in Cancer Patients: The MOUSEION-04 Study
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Towards a new WHO classification of renal cell tumor: what the clinician needs to know—a narrative review
por: Cimadamore, Alessia, et al.
Publicado: (2021)

TNM staging towards a personalized approach in metastatic urothelial carcinoma: what will the future be like?—a narrative review
por: Rizzo, Alessandro, et al.
Publicado: (2021)

Patient with Morning Glory syndrome
por: Martins, Thiago Gonçalves dos Santos, et al.
Publicado: (2015)

Molecular Mechanisms Related to Hormone Inhibition Resistance in Prostate Cancer
por: Mollica, Veronica, et al.
Publicado: (2019)

Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid Biopsy
por: Cimadamore, Alessia, et al.
Publicado: (2019)

Resistance to Systemic Agents in Renal Cell Carcinoma Predict and Overcome Genomic Strategies Adopted by Tumor
por: Mollica, Veronica, et al.
Publicado: (2019)

Breaking down barriers in morning glories
por: Field, David L., et al.
Publicado: (2019)

Current Strategies and Novel Therapeutic Approaches for Metastatic Urothelial Carcinoma
por: Mollica, Veronica, et al.
Publicado: (2020)

Update on Circulating Tumor Cells in Genitourinary Tumors with Focus on Prostate Cancer
por: Cimadamore, Alessia, et al.
Publicado: (2020)

Morning Glory Syndrome Associated with Posterior Lenticonus
por: Cao, Xiao-Guang, et al.
Publicado: (2009)

Morning glory disc anomaly with contractile movements
por: Sawada, Yu, et al.
Publicado: (2012)

Morning glory syndrome associated with multiple sclerosis
por: Safari, Anahid, et al.
Publicado: (2014)

Phylogenetic Patterns of Swainsonine Presence in Morning Glories
por: Quach, Quynh N., et al.
Publicado: (2022)

Conceptual Analogies Between Multi-Scale Feeding and Feedback Cycles in Supermassive Black Hole and Cancer Environments
por: Santoni, Matteo, et al.
Publicado: (2021)

Circulating Tumor Cells in Renal Cell Carcinoma: Recent Findings and Future Challenges
por: Santoni, Matteo, et al.
Publicado: (2019)

Microbiome and Cancers, With Focus on Genitourinary Tumors
por: Cimadamore, Alessia, et al.
Publicado: (2019)

Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer
por: Montironi, Rodolfo, et al.
Publicado: (2020)

Narrative review: predicting future molecular and clinical profiles of prostate cancer in the United States
por: Santoni, Matteo, et al.
Publicado: (2021)

Narrative review of prostate cancer grading systems: will the Gleason scores be replaced by the Grade Groups?
por: Montironi, Rodolfo, et al.
Publicado: (2021)

Prostate Cancer in 2021: Novelties in Prognostic and Therapeutic Biomarker Evaluation
por: Cimadamore, Alessia, et al.
Publicado: (2021)

The Role of Artificial Intelligence in the Diagnosis and Prognosis of Renal Cell Tumors
por: Giulietti, Matteo, et al.
Publicado: (2021)

Immunotherapy in renal cell carcinoma: latest evidence and clinical implications
por: Santoni, Matteo, et al.
Publicado: (2018)

Editorial: Emerging Biomarkers in Genitourinary Tumors
por: Montironi, Rodolfo, et al.
Publicado: (2019)

The Human Microbiota and Prostate Cancer: Friend or Foe?
por: Massari, Francesco, et al.
Publicado: (2019)

Identification and determination of ergot alkaloids in Morning Glory cultivars
por: Nowak, Julia, et al.
Publicado: (2016)

Parallel evolution of storage roots in morning glories (Convolvulaceae)
por: Eserman, Lauren A., et al.
Publicado: (2018)

New Frontiers in Prostate Cancer Treatment: Are We Ready for Drug Combinations with Novel Agents?
por: Aurilio, Gaetano, et al.
Publicado: (2020)

Narrative review: update on immunotherapy and pathological features in patients with bladder cancer
por: Aurilio, Gaetano, et al.
Publicado: (2021)

Agent-Based Learning Model for the Obesity Paradox in RCC
por: Belenchia, Matteo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j6fh6ohejkm0vl2ok9bgjf8dhq